Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration
- Author
- YUSUFI, Babur1 ; MUKHERJEE, Sujoy1 ; FLANAGAN, Robert2 ; PATON, Carol3 ; DUNN, Graham4 ; PAGE, Eleanor3 ; BARNES, Thomas R. E3
[1] West London Mental Health NHS Trust, Manchester, United Kingdom
[2] Medical Toxicology Unit, Guy's and St Thomas'NHS Foundation Trust, Manchester, United Kingdom
[3] imperial College Faculty of Medicine, Department of Psychological Medicine, London, Bulgaria
[4] Division of Epidemiology and Health Sciences, University of Manchester, Manchester, United Kingdom - Source
International clinical psychopharmacology. 2007, Vol 22, Num 4, pp 238-243, 6 p ; ref : 3/4 p
- ISSN
- 0268-1315
- Scientific domain
- Pharmacology drugs; Psychology, psychopathology, psychiatry
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- Antipsychotic Non-neurological Side Effects Rating Scale score clozapine plasma concentrations clozapine non-neurological side effects systematic assessment
- Keyword (fr)
- Antipsychotique Chimiothérapie Clozapine Echelle d'évaluation Epidémiologie Evaluation Homme Neuroleptique Pharmacocinétique Prévalence Psychotrope Santé publique Toxicité Traitement entretien Dibenzodiazépine dérivé Antagoniste Récepteur dopaminergique D2
- Keyword (en)
- Antipsychotic Chemotherapy Clozapine Evaluation scale Epidemiology Evaluation Human Neuroleptic Pharmacokinetics Prevalence Psychotropic Public health Toxicity Maintenance treatment Antagonist D2 Dopamine receptor
- Keyword (es)
- Antipsicótico Quimioterapia Clozapina Escala evaluación Epidemiología Evaluación Hombre Neuroléptico Farmacocinética Prevalencia Psicotropo Salud pública Toxicidad Tratamiento sostén Antagonista Receptor dopaminérgico D2
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B03 Psycholeptics: tranquillizer, neuroleptic.
- Discipline
- Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
- Origin
- Inist-CNRS
- Database
- FRANCIS ; PASCAL
- INIST identifier
- 18794001
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1097/YIC.0b013e32819f8f17 
https://dx.doi.org/10.1097/YIC.0b013e32819f8f17
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/YIC.0b013e32819f8f17\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:142:\"Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration\";s:9:\"\u0000*\u0000jtitle\";s:41:\"International clinical psychopharmacology\";s:9:\"\u0000*\u0000stitle\";s:26:\"Int. clin. psychopharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"22\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"238\";s:8:\"\u0000*\u0000epage\";s:3:\"243\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0268-1315\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"YUSUFI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Babur\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:16:\"MUKHERJEE, Sujoy\";i:1;s:16:\"FLANAGAN, Robert\";i:2;s:12:\"PATON, Carol\";i:3;s:12:\"DUNN, Graham\";i:4;s:13:\"PAGE, Eleanor\";i:5;s:19:\"BARNES, Thomas R. E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:142:\"Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/YIC.0b013e32819f8f17\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:142:\"Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration\";s:9:\"\u0000*\u0000jtitle\";s:41:\"International clinical psychopharmacology\";s:9:\"\u0000*\u0000stitle\";s:26:\"Int. clin. psychopharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"22\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"238\";s:8:\"\u0000*\u0000epage\";s:3:\"243\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0268-1315\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"YUSUFI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Babur\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:16:\"MUKHERJEE, Sujoy\";i:1;s:16:\"FLANAGAN, Robert\";i:2;s:12:\"PATON, Carol\";i:3;s:12:\"DUNN, Graham\";i:4;s:13:\"PAGE, Eleanor\";i:5;s:19:\"BARNES, Thomas R. E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:142:\"Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/YIC.0b013e32819f8f17\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/YIC.0b013e32819f8f17\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:142:\"Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration\";s:9:\"\u0000*\u0000jtitle\";s:41:\"International clinical psychopharmacology\";s:9:\"\u0000*\u0000stitle\";s:26:\"Int. clin. psychopharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"22\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"238\";s:8:\"\u0000*\u0000epage\";s:3:\"243\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0268-1315\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"YUSUFI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Babur\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:16:\"MUKHERJEE, Sujoy\";i:1;s:16:\"FLANAGAN, Robert\";i:2;s:12:\"PATON, Carol\";i:3;s:12:\"DUNN, Graham\";i:4;s:13:\"PAGE, Eleanor\";i:5;s:19:\"BARNES, Thomas R. E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:142:\"Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/YIC.0b013e32819f8f17\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:142:\"Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration\";s:9:\"\u0000*\u0000jtitle\";s:41:\"International clinical psychopharmacology\";s:9:\"\u0000*\u0000stitle\";s:26:\"Int. clin. psychopharmacol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"22\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"238\";s:8:\"\u0000*\u0000epage\";s:3:\"243\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0268-1315\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"YUSUFI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Babur\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:16:\"MUKHERJEE, Sujoy\";i:1;s:16:\"FLANAGAN, Robert\";i:2;s:12:\"PATON, Carol\";i:3;s:12:\"DUNN, Graham\";i:4;s:13:\"PAGE, Eleanor\";i:5;s:19:\"BARNES, Thomas R. E\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:142:\"Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
